Targeting tfeb and TFE3 in renal tumorigenesis
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210963
- Recipient
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $648,276
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Boston, MA 02115, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded Brigham & Women's Hospital Inc. a $648,276 Project Grant under the Military Medical Research and Development program. The three-year award will fund research from September 2022 to September 2025 to target TFEB and TFE3 in renal tumorigenesis.
The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative research and investigating medical solutions for battlefield wounds. This award will advance those goals by furthering the scientific understanding of renal cancer development and identifying potential therapeutic targets, thereby working to improve outcomes for service members and the general public suffering from this disease.
Quick answers
Who received award W81XWH2210963?
W81XWH2210963 was awarded to Brigham & Womens Hospital Inc. by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2210963 worth?
$648,276 has been obligated on W81XWH2210963.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award